Loading news...
Discounted PEG screen highlights four value stocks, led by healthcare. One can pick Exelixis, alongside DaVita, Phibro and Allison Transmission.
After an extended slump, DaVita may be primed for recovery, following a well-received quarterly earnings release. Berkshire may be cutting its losses on its Kraft Heinz investment, but for new investors, an opportunity to profit may be just around the corner.
Truist Financial Corp grew its stake in DaVita Inc. (NYSE: DVA) by 48.4% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 12,832 shares of the company's stock after purchasing an additional 4,186 shares during the period. Truist Financial Corp's holdings in
Shares of DaVita Inc. (NYSE: DVA - Get Free Report) have received a consensus rating of "Hold" from the seven analysts that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell recommendation, four have given a hold recommendation, one has assigned a buy recommendation and one has issued
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m.
BI Asset Management Fondsmaeglerselskab A S lowered its stake in shares of DaVita Inc. (NYSE: DVA) by 43.2% during the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 52,606 shares of the company's stock after selling 40,035 shares during the period.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Buffett's portfolio moves are a clear reflection of what he thinks about the stock market right now.
Although former Berkshire Hathaway (NYSE:BRK-B) CEO Warren Buffett retired as the company's chief executive, his legacy looms large.
DaVita Inc. (NYSE: DVA) stock surged on Tuesday after the company reported upbeat fourth-quarter earnings and fiscal 2026 guidance.
Shares of kidney dialysis treatment company DaVita understandably struggled in 2025. Its most recent quarterly report and guidance for the year ahead, however, were both better than anticipated.
Dow briefly hits a new record before trimming gains as traders pulled out of tech stocks
Major equities indexes fell Tuesday, although the Dow Jones Industrial Average hit a new all-time high before slipping. Meanwhile, gold and silver futures resumed their ascent.
DVA reports a fourth-quarter 2025 earnings and revenue beat as margins expanded and full-year adjusted EPS rose by double digits.
The AI trade is helping Teradyne (TER), with Diane King Hall pointing to the company's latest earnings as a signal of forward strength. Outside of tech, she notes DaVita's (DVA) earnings beat and guidance above expectations as it recovers from a malware attack.
DaVita (DVA) delivered a strong earnings beat, driving a 13.5%+ share price surge and reinforcing my positive outlook. DVA's strategy leverages home dialysis, integrated kidney care, and international expansion, supporting double-digit growth and margin stability despite sector headwinds. I maintain a fair value of $185/share and a price target of $130/share, reiterating a 'BUY' rating even after the recent upswing.
Mirae Asset Global Investments Co. Ltd. lifted its position in DaVita Inc. (NYSE: DVA) by 175.1% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 18,409 shares of the company's stock after acquiring an additional 11,718 shares
Adjusted Operating Income (Q4 2025): $586 millionFull-Year Adjusted Operating Income (2025): $2.094 billionAdjusted Earnings Per Share (Q4 2025): $3.40Full-Yea
DaVita Inc. (DVA) Q4 2025 Earnings Call Transcript